Fenfluramine (HCl)
Fenfluramine (HCl) is antiobesity drug and has anorectic effects. Fenfluramine (HCl) is a racemic chemical, closely related to amphetamine. It was introduced as an anorexigenic drug more than a decade ago in Europe. its d-isomer, d-fenfluramine is about twice as potent an anorexigenic drug as fenfluramine, suggesting that all of the fenfluramine activity reside in the d-form.
Primary Characteristics
It is of Synthetic origin and belongs to Anphetamine.
It belongs to Anorectic Agent pharmacological group on the basis of mechanism of action and also classified in Selective Serotonin Reuptake Inhibitor pharmacological group. It is also classified under CNS Stimulant .
Molecular Weight: 267.7 · pKa: 10 · Solubility in Water: 1 in 20 · Solubility in Alcohol: 1 in 10 · Non-proprietary name: Fenfluramine (HCl).

Pharmacokinetics
Absorption: Fenfluramine (HCl) has an oral bioavailability is 97% (±2%).
Distribution: Fenfluramine (HCl) has a plasma protein binding is 30%.
Elimination: it is metabolised via extensive by Liver, plasma half-life is 11-30 hr, renal excretion is >90%.
Advertisement
Indications
Fenfluramine (HCl) is primarily indicated in conditions like Obesity.
Fenfluramine (HCl) is also indicated for secondary conditions like Hypertension, Maturity onset diabetes.
Contraindications
Fenfluramine (HCl) is contraindicated in conditions like Depression, Mania, Cardiovascular disease.
Dosage
Fenfluramine (HCl)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 0 – 20 mg | — | Every 12h | PO | Intially for 1 Week |
| 40 – 80 mg | — | Every 12h | PO | Maintenance, As Required |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | — | Not Recommended in this Age Group |
| Neonatal Dosage (3kg) | ||||
| 0 – 0 | — | — | Not recommended in this age group | |
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Fenfluramine (HCl) in overdosage may give rise to further complications which include Tachycardia , Impotence , Anorexia , Coma , Depression , Dizziness , Respiratory depression , Abdominal cramps.
Fenfluramine (HCl) produces potentially life-threatening effects which include Blood dyscrasias, Pulmonary hypertension. Careful monitoring is needed with proper medical management.
The signs and symptoms that are produced after acute overdosage of Fenfluramine (HCl) are Flushing, Tachycardia , Cardiac arrhythmias, Convulsions , Coma, Hyperthermia, Hallucinations , Sweating , Tachypnea, Hyperpyrexia, Tremor, Mydriasis, Nystagmus, Excitation , Sweating, Increased tendon reflexes, Chest pain.
Fenfluramine (HCl) is known to cause more or less tolerable side effects which are usually transient. These include Diarrhea, Dizziness, Drowsiness, Dry mouth, Impotence, Insomnia, Irritability, Lethargy, Loss of libido, Nausea, Rashes , Restlessness, Urinary frequency, Vomiting .
Warnings / Precautions
Interference in Pathology
Fenfluramine (HCl) may interfere in the diagnosis of Plasma Cortisol Measurement. , Serum Triglycerides Measurement. .
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.17.10 — Antiobesity preparations